Martin Shkreli Resigns From Turing Pharmaceuticals
Mr. Shkreli was charged with fraud this week related to activities at a hedge fund he ran and at an earlier pharmaceutical company.
Articles Written By: ANDREW POLLACK
This author has written 2 articles
News Analysis: Martin Shkreli’s Arrest Gives Drug Makers Cover
Pharmaceutical executives can look at the federal indictment and say that Martin Shkreli is an aberration, a rotten apple, but his arrest is not likely to make concern about drug prices go away.